Norvasc (Amlodipine Besilate)


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 29.9%
Product Used For Unknown Indication 15.6%
Hypertension 13.0%
Drug Use For Unknown Indication 10.4%
Blood Pressure High 5.2%
Acute Promyelocytic Leukemia 3.9%
Breast Cancer 3.9%
Type 2 Diabetes Mellitus 3.9%
Plasma Cell Myeloma 2.6%
Blood Cholesterol Increased 1.3%
Blood Glucose Increased 1.3%
Chest Pain 1.3%
Constipation 1.3%
Depression 1.3%
Diabetic Neuropathy 1.3%
Multiple Sclerosis 1.3%
Renal Transplant 1.3%
Type Iia Hyperlipidaemia 1.3%
Depression 5.0%
Drug Hypersensitivity 5.0%
Ear Infection 5.0%
Gallbladder Operation 5.0%
Ileus 5.0%
Influenza Like Illness 5.0%
Myocardial Infarction 5.0%
Nausea 5.0%
Neoplasm 5.0%
Pain 5.0%
Pancreatitis 5.0%
Rash Generalised 5.0%
Renal Failure Acute 5.0%
Retinal Ischaemia 5.0%
Sluggishness 5.0%
Syncope 5.0%
Therapy Cessation 5.0%
Tremor 5.0%
Weight Decreased 5.0%
White Blood Cell Count Decreased 5.0%
Concomitant
Plasma Cell Myeloma 18.8%
Product Used For Unknown Indication 10.8%
Nephrogenic Anaemia 8.5%
Chronic Myeloid Leukaemia 8.0%
Type 2 Diabetes Mellitus 8.0%
Hypertension 6.8%
Multiple Sclerosis 6.3%
Prostate Cancer Metastatic 5.7%
Osteoporosis 5.1%
Osteoporosis Prophylaxis 4.5%
Gait Disturbance 3.4%
Diabetes Mellitus 2.8%
Depression 2.3%
Iron Deficiency Anaemia 1.7%
Tuberous Sclerosis 1.7%
Actinic Keratosis 1.1%
Acute Myeloid Leukaemia 1.1%
Anticoagulant Therapy 1.1%
Application Site Anaesthesia 1.1%
Blood Pressure 1.1%
Vomiting 15.9%
Pyrexia 7.3%
Weight Decreased 7.3%
Deep Vein Thrombosis 4.9%
Nausea 4.9%
Pancreatitis 4.9%
Pneumonia 4.9%
Urinary Tract Infection 4.9%
Urticaria 4.9%
Hypertension 3.7%
Pain In Extremity 3.7%
Pancreatitis Acute 3.7%
Quality Of Life Decreased 3.7%
Rash 3.7%
Renal Failure Acute 3.7%
Sepsis 3.7%
Stress Fracture 3.7%
Tachycardia 3.7%
Tremor 3.7%
Vision Blurred 3.7%

Drug Data